Statistics

Total Visits

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study68

Select a period of time:

Number of views in the range

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study29

Views

Views
November 20251
December 20252
January 20263
February 20260
March 20262
April 20266
May 202615
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Germany3
Spain2
Brazil2
Argentina1
Bolivia1
Dominican Republic1
Ecuador1
France1
Ireland1
 

Top cities views

Views
San Jose3
Alta Floresta1
Benejúzar1
Chicago1
Cochabamba1
Corrientes1
Dublin1
Fayetteville1
Frankfurt am Main1
Gondomar1